Position in ARGX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,059,921
+$1,117,744 QoQ
Shares Held
4,376
+8.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#159
of 504 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethic Inc. holds $40,271,041 across 35 Biotechnology names. ARGX ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,947 | $10,405,003 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,069 | $10,019,664 | |
| 3 | ARGX |
Argenx SE
This page
|
4,376 | $4,059,921 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
31,679 | $2,511,827 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,965 | $1,615,628 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,172 | $1,556,927 | |
| 7 | MRNA |
Moderna, Inc.
|
15,694 | $1,099,050 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
9,345 | $885,438 |
All Filings in ARGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,059,921 | 4,376 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,942,177 | 4,029 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,435,280 | 4,085 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $825,329 | 1,119 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $552,873 | 1,003 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $697,216 | 1,178 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $756,450 | 1,230 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $298,017 | 693 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $310,811 | 817 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $313,659 | 638 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||